Charles Perou, PhD, appointed May Goldman Shaw Distinguished Professorship of Molecular Oncology Research
Chapel Hill, NC – Charles M. Perou, PhD, professor of genetics, and pathology & laboratory medicine, and leader of the UNC Lineberger Comprehensive Cancer Center breast cancer research program has been appointed the May Goldman Shaw Distinguished Professor of Molecular Oncology Research. The professorship, established by a $1 million gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas is named in honor of Mrs. Lowenbaum’s mother, May Goldman Shaw.
CHAPEL HILL, NC – In a kind of molecular gymnastics, scientists at the University of North Carolina at Chapel Hill School of Medicine have devised a gene therapy cocktail that has the potential to treat some inherited diseases associated with “misfolded” proteins.
New television ads for UNC Cancer Care are now airing. As we launch the UNC Cancer Care brand, we hope these ads reflect a little bit of what our outstanding clinical care programs are all about. Be sure to look for them on television! The ads can also be viewed below.
Chapel Hill - University of North Carolina at Chapel Hill researcher Joseph DeSimone, PhD, will partner with scientists at two universities and a local biotechnology company to develop a nanoparticle vaccine for prostate cancer. The Prostate Cancer Foundation awarded the UNC-Beth Israel Deaconess Medical Center/Harvard-Johns Hopkins-Liquidia Technologies consortium a Challenge Award of $1 million, one of ten such awards funded by the organization.
Cancer is a leading cause of widowed fatherhood in the United States. Faculty with UNC Lineberger Comprehensive Cancer Center’s Comprehensive Cancer Support Program authored a commentary titled “Single Fatherhood Due to Cancer” in the August issue of the journal Psycho-Oncology outlining challenges these fathers face and future directions to develop supportive interventions for them and their children.
Stephan Moll, MD, is quoted in an article titled "Blood Clots Pose Threat to All of Us," published today on Fox Business' website.
Six new residents have begun their training with the UNC Department of Radiation Oncology.
Karyn Stitzenberg, MD, MPH, is quoted in an article titled "Tracking the Rise of Robotic Surgery for Prostate Cancer" published in the August 9, 2011 issue of the NCI Cancer Bulletin.
Angelique Whitehurst, PhD, and her Stand Up to Cancer research grant were featured in an article in the August 2011 issue of Nature Medicine.
Marci Campbell, PhD, MPH, RD, authored a guest editorial titled "Cancer is a Team Sport" for the August 2011 issue of the Clinical Journal of Oncology Nursing.
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, talks with Kristy Villa, one of the hosts of Lifetime Television’s “The Balancing Act" about colon cancer.
Discovery may have implications for many diseases
Chapel Hill, NC – Lisa A. Carey, MD, Professor of Medicine, Medical Director of the UNC Breast Center and Associate Director for Clinical Research at UNC Lineberger Comprehensive Cancer Center has been appointed The Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research.
Project will assess needs and work to accelerate adoption of evidence-based cancer prevention interventions
From Pamplona to Portomarin, from Sarria to Santiago, from Fromista to Fisterra, a group from Chapel Hill covered a lot of ground this summer, literally.
RALEIGH, NC – Crown Imports announced today that the highly successful “Corona Cares” charitable donation program in North Carolina will kick off on August 1 to benefit patients and families at the N.C. Cancer Hospital.
Male circumcision lowers prevalence of penile precancerous lesions among African men, UNC study finds
Chapel Hill - A University of North Carolina-led international study shows that among Kenyan men, circumcision is associated with a lower prevalence of human papillomavirus-associated precancerous lesions of the penis.
The article "Oncologists by day, rock stars by night” written by Rachel Saslow and published in The Washington Post on July 25, 2011 features the band, N.E.D (which stands for “No Evidence of Disease”).
When Emily Bright was diagnosed with ovarian cancer at the age of 23, she decided to get off the couch and started running. Never much of an athlete before, she eventually built up the strength to run not one, but two, half marathons!
Ken Jacobson, PhD, Kenan Professor of Cell and Developmental Biology in the UNC School of Medicine, received the Gregorio Weber Award for Excellence in Fluorescence Theory and Applications at the annual meeting of the Biophysical Society in Baltimore, Maryland.